Recalcitrant dermatophyte infection

Dermatologic Therapy

Volumn 3, Issue , 1997, Pages 75-78

  Svejgaard, Else L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001904772     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hay RJ. Chronic dermatophyte infections. I Clinical and mycological features. Br J Dermatol 1982: 106: 1-7.
2. Svejgaard E. Dermatophytes and dermatophytosis. Semin Dermatol 1985: 4: 201-221.
3. Dahl MV. Dermatophytosis and the immune response. J Am Acad Dermatol 1994: 31: 534-541.
4. Davies RR, Zaini F. Enzymic activities of Trichophyton rubrum and the chemotaxis of polymorphonuclear leukocytes. Sabouraudia J Med Vet Mycol 1984: 22: 235-241.
5. Grando SA, Hostager BS, Herron MJ, Dahl MV, Nelson RD. Binding and uptake of Trichophyton rubrum mannan by human epidermal keratinocytes: a time course study. Acta Derm Venereol (Stockh) 1992: 72: 273-276.
6. Leyden JL. Tinea pedis pathophysiology and treatment. J Am Acad Dermatol 1994: 31: 531-533.
7. Evans EGV, Dodman B, Williamson DM, Brown GJ, Bowen RG. Comparison of terbinafine and clotrimazole in tinea pedis. Br Med J 1993: 307: 645-647.
8. Savin RC. Treatment of chronic tinea pedis (athlete's foot type) with topical terbinafine. J Am Acad Dermatol 1990: 23: 786-789.
9. Cauwenbergh G, Degreef H, Heykants J et al. Pharmacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988: 18: 263-268.
10. Decroix J. Tinea pedis (moccasin type) treated with itraconazole. Int J Dermatol 1995: 34: 122-124.
11. Hay RJ, Clayton YM, Moore MK, Midgeley G. Itraconazole in the management of chronic dermatophytosis. J Am Acad Dermatol 1990: 23: 561-564.
12. De Doncker P, Cauwenberg G. Management of fungal skin infections with 15 days itraconazole treatments worldwide review. Br J Clin Pract Symp Suppl 1990: 71: 118-122.
13. Faergemann J, Zehender H, Jones T, Maibach I. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Derm Venereol (Stockh) 1991: 71: 322-326.
14. Savin RJ, Zaias N. Treatment of chronic moccasin-type tinea pedis with terbinafine: a double blind, placebo controlled trial. J Am Acad Dermatol 1990: 23: 804-807.
15. Savin R. Successful treatment of chronic tinea pedis (moccasin type) with terbinafine (Lamisil). Clin Exp Dermatol 1989: 14: 116-119.
16. Wite JE, Perkins PJ, Evans EGV. Successful 2-week treatment with terbinafine (Lamisil®) for moccasin tinea pedis and tinea manuum. Br J Dermatol 1991: 125: 260-262.
17. De Keyser P, De Backer M, Massart DL, Westelinck KJ. Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day with itraconazole 100 mg/day): a double-blind, multicenter study. Br J Dermatol 1994: 130(suppl 43): 22-25.
18. Hay RJ, McGregor JM, White J et al. A comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar type tinea pedis. Br J Dermatol 1995: 132: 604-608.
19. Budimulja V, Kuswadji K, Bramono S et al. A double-blind randomized, stratified controlled study of the treatment of tinea imbricata with oral terbinafine or itraconazole. Br J Dermatol 1994: 130(suppl 43): 29-31.